Categories: HealthcareNews

Streamline Health® Expands RevID™ Agreement with Large Provider Network, Achieves Booked SaaS ACV Goal

National Health System Expands Utilization of RevID’s Automated Charge Reconciliation for Improved Financial Performance; Company Exceeds $17M of Booked SaaS ACV 

Atlanta, GA, Jan. 19, 2023 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced today an expansion of its existing relationship with a prominent healthcare system that manages 80+ facilities throughout the United States. The health system has further expanded its use of RevID. The Company also announced that it has now exceeded its previously stated goal of $17 million of booked SaaS ACV by the end of its fiscal 2022.

Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID’s automated charge reconciliation ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide.

“We are pleased that this key healthcare provider continues to expand utilization of our novel RevID solution and thrilled that our sales team was able to execute on its SaaS bookings goals thus far in fiscal 2022” stated Ben Stilwill, President, Streamline Health. “We look forward to continued growth as a result of our mission to ensure that our nation’s healthcare providers are paid for the care they provide.”

About Streamline Health

Streamline Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance. We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. For more information, visit www.streamlinehealth.net

To Learn More

Media
David Kosloski
Vice President, Marketing & Communications
651.308.1395
david.kosloski@streamlinehealth.net

Investors
Jacob Goldberger
Director, Investor Relations and FP&A
303.887.9625
jacob.goldberger@streamlinehealth.net

Staff

Recent Posts

TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

HighlightsNewly granted patent protects TempraMed's VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architectureExpands the…

44 minutes ago

Functional Brands Announces Third Quarter 2025 Financial Results

Lake Oswego, Oregon--(Newsfile Corp. - December 15, 2025) - Functional Brands Inc. (NASDAQ: MEHA), a…

44 minutes ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

TYLER, Texas--(BUSINESS WIRE)--ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a medical technology company…

6 hours ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

TYLER, Texas--(BUSINESS WIRE)--ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a medical technology company…

6 hours ago

Detect-ION Launches Collaborative Project to Develop Breath-Based Diagnostics for Pneumonia-Causing Pathogens

TAMPA, Fla., Dec. 15, 2025 /PRNewswire/ -- Detect-ION, LLC, a health-tech startup based in Tampa,…

6 hours ago